Product
NNC0363-0845
2 clinical trials
3 indications
Indication
Diabetes MellitusIndication
Type 1Indication
Healthy Control ParticipantsClinical trial
A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 DiabetesStatus: Completed, Estimated PCD: 2022-05-06
Clinical trial
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Healthy Subjects and in Subjects With Type 1 DiabetesStatus: Completed, Estimated PCD: 2021-06-23